IPW
WVE icon

Impact Partnership Wealth’s Wave Life Sciences WVE Stock Holding History

Impact Partnership Wealth’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-276
Closed -$1K – 1230
2023
Q2 		$1K Buy
+276
New +$1.11K ﹤0.01% 793

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Impact Partnership Wealth's WVE Position: Q3 2023 in Review

Impact Partnership Wealth sold out of Wave Life Sciences (WVE) in Q3 2023, closing a stake of 276 shares — an estimated $1K sold.

Impact Partnership Wealth first reported a position in WVE in Q2 2023 and held it in 1 quarter. The position peaked at $1K in Q2 2023. 85 funds tracked by Wall St. Rank hold WVE as of Q3 2023.

  • Impact Partnership Wealth reported no remaining Wave Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 276 Wave Life Sciences shares in Q3 2023, an estimated $1K.
  • Impact Partnership Wealth first reported a position in Wave Life Sciences in Q2 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's Wave Life Sciences position peaked at $1K in Q2 2023.
  • 85 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.